Successful Treatment of Refractory Cancer Pain and Depression with Continuous Intrathecal Administration of Dexmedetomidine and Morphine: A Case Report
Abstract Patients who have refractory cancer pain suffer both physically and psychologically. Cancer pain management has improved over the past few decades. However, the treatment of refractory cancer pain is still challenging all over the world. Intraspinal analgesia has become an effective strateg...
Main Authors: | Ge Huang, Guo Liu, Zhiguo Zhou, Jinfeng Yang, Chen Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-07-01
|
Series: | Pain and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40122-020-00183-3 |
Similar Items
-
Evaluation of the neurotoxicity of intrathecal dexmedetomidine on rat spinal cord (electromicroscopic observations)
by: Dilek Ozdamar, et al.
Published: (2018-01-01) -
Comparative study of morphine or dexmedetomidine as intrathecal adjuvants to 0.5% hyperbaric bupivacaine in infraumbilical surgeries
by: Mamta Khandelwal, et al.
Published: (2019-01-01) -
Dexmedetomidine versus midazolam as adjuvants to intrathecal bupivacaine: A clinical comparison
by: Usha Shukla, et al.
Published: (2016-01-01) -
A comparative clinical study of intrathecal bupivacaine 2.5 mg with dexmedetomidine 5 μg versus intrathecal bupivacaine 2.5 mg with fentanyl 25 μg on the duration of labor analgesia using combined spinal epidural technique
by: Neena Jain, et al.
Published: (2019-01-01) -
A Comparative Evaluation of Dexmedetomidine and Clonidine as an Adjunct with Intrathecal Inj. Levobupivacaine in Spinal Anaesthesia
by: Vania Kanvee, et al.
Published: (2015-03-01)